Evidence map›Paper›PMID 35237234›Full record

ArticleFrontiers in endocrinology2022

Outcomes After a Single Ovarian Stimulation Cycle in Women of Advanced Reproductive Age: A Retrospective Analysis.

Mengdi Liu, Xusheng Zhao, Yuanyuan Peng, Jiahua Zheng, Kaixuan Guo, Yanli Fan, Lei Jiang, Aimin Yang, Na Cui, Guimin Hao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mengdi LiuThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Xusheng ZhaoThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yuanyuan PengThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Jiahua ZhengThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Kaixuan GuoThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yanli FanThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Lei JiangThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Aimin YangThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Na CuiThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Guimin HaoThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Wei WangThe Second Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei Medical University · CNSecond Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPrevious studies showed that age is the most important factor that determines the outcome after embryo transfer (ET), with either

methodsThis retrospective analysis included all women of advanced reproductive age (38 years or older) undergoing IVF or ICSI at authors' institute during a period from January 1, 2016 to December 31, 2018. The study protocol was approved by the Ethics Committee of the Second Hospital of Hebei Medical University (No. 2021-P045). Subjects with underlying diseases were excluded from analysis. The last follow-up was conducted in December 2020, with minimal 2-year follow-up.

resultsThe final analysis included 826 women (40.00 ± 2.10 years of age at the time of ovarian stimulation; n = 633 and 193 for IVF-ET and ICSI-ET, respectively). The number of women in each age bracket was: 424 for 38/39 y, 226 for 40/41 y, 118 for 42/43 y, and 58 for ≥44 y. The number of transferable embryos was 2 (interquartile range: 2,4) for 38/39 y, 2 (2,3) for 40/41 y, 2 (2,3) for 42/43 y, and 2 (1.75,3) for ≥44 y. The rate of fresh embryo transfer was comparable (62.03-72.58%) among the 4 age brackets. The average CLBR following a single cycle was 26.27% in the overall study population, 32.31% for 38/39 y, 26.99% for 40/41 y, 14.4% for 42/43 y, and 3.44% for ≥44 y (

conclusionsForty-two years of age seemed to be a critical cutoff to achieve reasonable level of CLBR after a single ovarian stimulation cycle in women of advanced reproductive age.

Indexed as

Live BirthOvulation InductionAdultFemaleGonadotropin-Releasing HormoneHumansPregnancyPregnancy RateRetrospective StudiesGonadotropin-Releasing Hormoneadvanced reproductive ageassisted reproductive technologyintracytoplasmic sperm injectionin vitro fertilizationlive birth

Identifiers

PMID35237234
PMCPMC8882593
OpenAlexW4212800500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.